In skeletal muscles of patients with Duchennemuscular dystrophy (DMD),the absence of dystrophin was thought to lead to the large reduction in all of the dystrophin-associated proteins (DAPs). Of the seven types ofDAPs identified in skeletal muscle, only the 43-kDa glycoprotein ((3-dystroglycan) has recently been found in the monkey brain. To clarify the distribution and characterization of dystrophin and p-dystroglycan in the brain of humans, we carried out immunostaining and immunoblotting studies on tissues from three DMDpatients with intellectual disturbances (ages 17, 22, and 26 year) and in five controls (age range, 42-74 year). An antidystrophin antibody revealed dystrophin to be localized in neuronal cells and in the vascular wall in control brains, but it was absent from these tissues in DMDpatients. In contrast, p-dystroglycan was distributed throughout neuronal cells and in the vascular wall of control brains, and was well preserved in the brain of patients with DMD.
Introduction
The gene for Duchenne muscular dystrophy (DMD)encodes dystrophin, a large membranecytoskeletal protein found in skeletal muscle (1) (2) (3) (4) . This protein is localized on the inner surface of the sarcolemma in normal skeletal muscle, but is absent from the skeletal muscle of patients with DMD (5) (6) (7) (8) (9) . Since the discovery of dystrophin, dystrophin-associated proteins (DAPs) (10-15), utrophin (16, 17) , and several dystrophin isoforms such as Dp71 (18, 19) , , apodystrophin- 1 and -3 (21, 22) , and Dpi16 (23) have been described. Campbell and Kahl ( 1 0) demonstrated that dystrophin is tightly linked to a large oligomeric complex of sarcolemma glycoproteins. Ervasti et al (1 1) and Yoshida and Ozawa (15) showed that the glycoproteins are comprised of a 156-kDa glycoprotein (oc-dystroglycan), a 94-kDa protein (A0), three kinds of 59-kDa protein (a-, (3r, p2-syntrophins), a 50-kDa glycoprotein (a-sarcoglycan), two 43-kDa glycoproteins (pdystro-glycan and (3-sarcoglycan), a 35-kDa glycoprotein (ysarcoglycan), and a 25-kDaprotein (25DAP). Yoshida et al (24) showed that there is an additional 43 kDa glycoprotein (3- sarcoglycan which is differentiated from p-dystroglycan, on the basis of several criteria. It has been proposed that ocdystroglycan and P-dystroglycan span the sarcolemma to provide a link between the subsarcolemmal cytoskeleton and the extracellular matrix component, laminin (12, 25, 26 ). Campbell's group reported that, in the skeletal muscle of patients with DMD, the absence of dystrophin led to a large reduction in all DAPs (1 1, 25, 27) . Conversely, Yoshida et al (28) and Mizuno et al (29) demonstrated that p-dystroglycan is rather well retained in DMDmuscle, as compared with adhalin. p-dystroglycan and adhalin each belong to different groups of DAP(24). Wereported earlier on the localization of dystrophin and utrophin in humans (30) and in murine brains (31). We describe here the localization and characterization of dystrophin and p-dystroglycan in the human brain. 
Subjects and Methods
The brains and skeletal muscles were obtained at autopsy from three male patients (ages 17, 22, and 26 year) with DMD and from five controls (four menand one womanaged 42-74 year) who died from causes other than neurological or psychiatric disease. Autopsy was done within 4 hours of death. All of the subjects were Japanese. The recorded IQ scores of the three DMDpatients were 61, 68, and below 50, respectively (tested with the Wechsler Intelligence Scale for Children-Revised or the Wechsler Adult Intelligence Scale). Tissues were divided into frontal, parietal, and occipital lobes, cerebellum, and skeletal muscle and were immediately frozen in liquid nitrogencooled isopentane and stored in a deep freezer (-85°C) until the start of the experiments. For immunostaining, frozen sections were cut into 10 \im sections and stained by the avidin-biotinylated horseradish peroxidase method, as described previously (30, 31). For primary incubation, two types of region-specific antidystrophin antibodies were used: rabbit antidystrophin antibody (antibody 6-10) and mouse antidystrophin antibody (Dys-2; Novocastra Laboratories, Newcastle upon Tyne, UK). Antibody 6-10 is a polyclonal antibody that is produced in a rabbit immunized with a dystrophin polypeptide expressed in E. coli from dystrophin CDNAresidues 6, 544 ; it is excellent for the detection of brain-type dystrophin. Dys-2 is a monoclonal antibody raised 3, 5, 7) , but it is not evident in the DMDbrain (lanes 2, 4, 6, 8) . With antibody PA3a, the 43 kDa band (P-dystroglycan) was clearly evident in control skeletal muscle and brain. In DMD, the 43 kDa band was very faint in skeletal muscle, but was clearly noted in brain tissue.
Dystrophin and p-Dystroglycan in DMDBrain against the 3,669-3,685 (C terminus 
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Dystrophin and (3-Dystroglycan in DMDBrain 8.5). Ten micrograms of protein were electrophoresed through 3.5 to 12% SDS polyacrylamide gradient gels (1 mmx 10 cm x 9 cm) at 15 mAfor 2.5 hour. After transfer onto a membrane (Immobilon-P, Millipore Corporation, Bed ford, MA, USA), the specimen was blocked with 0.1% casein-0.1% gelatin in PBS overnight at 4°C; blots were stained with antidystrophin and anti-P-dystroglycan antibodies at roomtemperature for 2 hour. Dystrophin-antidystrophin and p-dystroglycan-anti-(3-dystroglycan immunecomplexes were detected with affinitypurified secondary antibodies conjugated to avidin-biotinylated horseradish peroxidase (Vecstain ABCkit and Elite ABCkit, Vector Laboratories, Burlingame, CA, USA). For statistical analysis, the P-dystroglycan band was measured using a densitometer (Cosmo F808, Cosmo Co. Tokyo, Japan).
Results

Immunoblots
Following immunoblots of the control cerebrum (frontal, parietal, and occipital lobes), cerebellum, and skeletal muscle, antibody 6-10 revealed a clear dystrophin band at 427 kDa and this band was absent in brain and skeletal muscles from DMD patients (Fig. 1A) . With Dys-2, no dystrophin band was noted in either control or DMD brains (data not shown). With antibody PA3a, the (3-dystroglycan band was clearly noted at 43 kDa in all brains examined and there was no significant difference in the density of the 43DAGband between DMDand control brains (Fig. IB) . The p-dystroglycan band of skeletal muscle was clear in controls, but very faint in advanced DMD.
Immunostain
With immunostaining, antibody 6-10 was localized in a punctate manner along the cell bodies and dendrites of cerebral cortical neurons and Purkinje cells of control brains, but was absent in the brains ofDMD (Fig. 2) . With Dys-2, the vascular wall was positively labeled in control brains, but cerebral cortical neurons and Purkinje cells did not stain positively in either control or DMDbrains. With antibody PA3a, the surface membranes of cerebral cortical neurons, Purkinje cells, pia mater, and the vascular wall were positively stained in all of the brains examined (Fig. 3) .
Discussion
The absence of dystrophin dramatically reduced all the DAPsin the sarcolemma of patients with DMDand of mdx mice (ll, 25, 27) . Yoshida et al (28) and Mizuno et al (32) demonstrated that p-dystroglycan is retained in DMDmuscles, as determined using anti-P-dystroglycan antibody (PA3a). In the present study, sarcolemmaof the DMD muscle was fairly well stained with PA3a but the amount of p-dystroglycan was reduced on immunoblots, probably due to the severe decrease in the total number of muscle fibers. In the DAPs, P-dystroglycan was present in monkey brain (32). We investigated the distribution and characterization of dystrophin and p-dystroglycan in the humanbrain. Although the localization of dystrophin in the In contrast, (3-dystroglycan was well distributed in the control brains and was well preserved in DMDbrains. Obviously, a deficiency of dystrophin does not always lead to a markedreduction of DAP in the DMDbrain. Retention of DAP43DAGmay possibly be related to the preservation of neurons in the DMDbrain. In DMDpatients, we confirmed that there is a lowering of the IQ and also an abnormality of event-related brain potentials (P-300) (unpublished data). Pillers et al (43) reported evidence of dystrophin in the outer plexiform layer of the humanretina, and found that five patients with Becker's dystrophy and six with Duchenne dystrophy had abnormal electroretinograms. These data suggest that dystrophin is related to the diversified physiological functions in tissues. 
